Drug Profile


Alternative Names: CL-871502; HN 11500

Latest Information Update: 07 Sep 2006

Price : $50

At a glance

  • Originator Amersham
  • Class Acetates; Antiplatelets; Small molecules; Thiophenes
  • Mechanism of Action Thromboxane A2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Thrombosis

Most Recent Events

  • 07 Sep 2006 Discontinued - Phase-II for Thrombosis in Austria (IV-injection)
  • 07 Sep 2006 Discontinued - Phase-II for Thrombosis in Austria (PO)
  • 13 Feb 1998 Suspended-II for Thrombosis in Austria (IV-injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top